Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. [8] Their tests samples are non-invasive urine test based on RNA and protein assays, with high sensitivity and earlier detection than other forms of bladder cancer diagnostics like cytology. Pacific Edge Ltd | 953 followers on LinkedIn. I can report that insiders do own shares in Pacific Edge Limited. What Is Insider Buying? Companies similar to or like Pacific Edge Limited. Efficiency) of 0.15, which implies the firm had 0.15% of return per unit of risk over the last 3 months. Company Profile. PEB $1.200 $0.010 / 0.84% 52 Week Change: $1.079 / 899.22%. Cancer molecular diagnostics company. Compare. PEB $0.640 -$0.020 / -3.03% 52 Week Change: $0.418 / 191.53%. UNLISTED). The average buy price was around NZ$0.17. PEB.NZX performance. It operates in two segments, Commercial and Research. Global Stock Market database including US, Canada, London, Singapore, Australia, Hong Kong, and New Zealand. [9][10][11][12][13][14], Pacific Edge has won a number of awards, including, Learn how and when to remove these template messages, Learn how and when to remove this template message, NZBIO Biotech company of the year award 2014, Medical Technology Association of New Zealand Innovation Award 2016, "PEB.NZ Profile - Pacific Edge Limited Ordinary S Stock - Yahoo! [read more] Nov 26th, 2020 Pacific Edge Announces HY Financial Results. Pacific Edge, the worlds number one saltwater bait tank since 1980. Pacific Edge Limited. | Pacific Edge Limited (NZX: PEB) is a New Zealand publicly-listed, cancer diagnostics company specialising in the discovery and commercialisation of diagnostic and prognostic tests for better detection and monitoring of cancer. Access 'Our View' Join Forsyth Barr to access 'Our View' for this stock and many others. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. The Woodland 'footprint' is now a cutting-edge facility -- three production lines spread over multiple buildings, a shipping and receiving department, office building, and a lean warehouse. actualites PACIFIC EDGE LIMITED (PFGTF) NZPEBE0002S1 et les informations boursières de la cotation sur le marché NO MARKET (E.G. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand.Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Sign up today for full access. Pacific Edge Featured on Bloomberg.com. Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. News & Research. Job Description. Join us Sign in. PACIFIC EDGE LIMITED : Agenda, historique des publications de résultats et attentes des analystes pour la société PACIFIC EDGE LIMITED | New Zealand Stock Exchange The state has a population of 10.5 million, which makes it great for those looking to buy a business in Georgia. Valuation. We provide high quality market information, featuring real time stock quotes, market data, market news and tools to … If you want to know who really controls Pacific Edge Limited (NZSE:PEB), then you'll have to look at the makeup of its share registry. Annual and quarterly financial reports, income statements and balance sheets for PACIFIC EDGE LIMITED (PEB) on MSN Money. Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. Pacific Index Edge is not available in New York. Pacific Edge Ltd. 1.19 NZD 0.010 0.85% Become a client . Georgia is a southern state along the Atlantic coast bordered to the south by Florida, the east by South Carolina and the west by Alabama. © 2021 Verizon Media. Pacific Edge Limited. It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. Pacific Edge Limited (NZX:PEB) A cancer diagnostic Company, Pacific Edge Limited is engaged in discovering, developing, and marketing cancer diagnostics tests. Pacific Edge Limited est une société de diagnostic du cancer. Tests using its Cxbladder technology for detecting and monitoring bladder cancer are sold in the US, New Zealand, Australia and Singapore. Cours Action PACIFIC EDGE LIMITED (PFGTF) NZPEBE0002S1 et les informations boursières de la cotation sur le marché NO MARKET (E.G. The firm is listed on the New Zealand NZX index. insider Tony Rankin purchased NZ$10k worth of shares in that period. It is not uncommon to see companies perform well in the years after insiders buy shares. New. King bed or double queen beds Gas fireplace Limited angled breakwater views from private balcony Bathroom features a raised landing (three steps up) with a jetted spa tub and separate shower Refrigerator with complimentary sodas and in-room Keurig coffee Two luxuriously soft robes Writing desk and iPod docking station Flat panel high definition television with […] Home Dividend Stocks Health Care Medical Equipment Devices Life … PACIFIC EDGE LIMITED was incorporated on 1 October 2019 (Tuesday) as a Private Limited Company in UK. Payout Estimate. Pacific Edge develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the early detection and management of cancer. Asia Pacific Browse thru Dachshund Puppies for Sale near Griffin, Georgia, USA area listings on PuppyFinder.com to find your perfect puppy. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. Payout History. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. The Company's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. Earned interest, which is … The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. Cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. Pacific Edge Limited shows a Profitability Score of N/A. The company is developing and commercialising its suite of Cxbladder bladder cancer tests globally through its wholly owned, and CLIA certified, laboratories in … Wikipedia. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. Recherchez les dernières actualités, les cotations boursières et l’historique PACIFIC EDGE LIMITED (PFGTF), ainsi que d’autres informations essentielles qui vous aideront dans vos transactions et … Pacific Edge Ltd. 1.19 NZD 0.010 0.85% Become a client . Pacific Edge Ltd | 953 followers on LinkedIn. Valuation. Used Bobcat T550 Compact Track Loader in Lagrange, Georgia, United States for sale, inspected and guaranteed. This means that Pacific Edge Limited has a lower profitability than its peer group. Pacific Edge Limited. Wikipedia. PEB.NZX performance. Pacific Edge Limited operates in the Commercial physical research sector. [6], In June 2020, Pacific Edge secured a commercial relationship with Kaiser Permanente, one of the largest health insurance providers in the US, for its bladder cancer tests. Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. Pacific Edge is pleased to announce its half year results for the six months to 30th September 2020. About the role: The COO role has overall responsibility for the manufacturing and production function across Pacific Edge and its franchise-like subsidiaries. It identifies gene and protein signatures for the development of cancer management tools. UNLISTED). Pacific Edge Limited is possibly approaching a major achievement in its business, so we would like to shine some light on the company.Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. The Profitability Score for Pacific Edge Limited is lower than its peer group's. It operates in two segments, Commercial and Research. Find the latest PACIFIC EDGE LIMITED (PFGTF) stock quote, history, news and other vital information to help you with your stock trading and investing. Pacific Edge Limited (NZX:PEB) A cancer diagnostic Company, Pacific Edge Limited is engaged in discovering, developing, and marketing cancer diagnostics tests. Discover new investment ideas by accessing unbiased, in-depth investment research, Other OTC - Other OTC Delayed Price. Découvrez les cours historiques pour les actions PFGTF sur Yahoo Finance. Pacific Edge insiders may have bought shares in the last year, but they didn't sell any. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. Annual and quarterly financial reports, income statements and balance sheets for PACIFIC EDGE LIMITED (PEB) on MSN Money. As individuals, the insiders collectively own NZ$67m worth of the NZ$835m company. Bloomberg.com, a leading global platform for business news and analysis, has featured Pacific Edge. They make genetic tests for over 200 different types of health concerns. Pacific Edge Limited is a cancer diagnostics company. The company has completed trials in colorectal cancer prognosis and bladder cancer detection. [3], Established in August 2001,[4] Pacific Edge uses genetic biomarkers in urine to detect the presence of cancer. Our capabilities include cancer genetics, molecular oncology, bioinformatics, clinical research, technology commercialisation, marketing and sales. Pacific Edge has made good ground in New Zealand with its test products, which offer a simple and low-cost screening method for bladder cancer, reducing the … They provide a diagnostic service through their facilities in New Zealand and the United States as well as selected partners in Europe and Australia. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand.Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. If you want to know who really controls Pacific Edge Limited ( NZSE:PEB ), then you'll have to look at the makeup of... Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. [7], Pacific Edge's suite of tests for bladder cancer are called CxBladder, with specialist sub-type products to detect cancerous cells and provide triage for clinicians and oncologists. Instrument Name: Pacific Edge Limited Ordinary Shares: Issued By: Pacific Edge Limited ISIN: NZPEBE0002S1: Type: Ordinary Shares: David Gregory Darling: Chief Executive Officer and Managing Director: 1035 exchange/transfer requests must be submitted with the application and the funds received within 60 days after contract issue. PACIFIC INDEX EDGE Purchase Payments Limited-premium, fixed indexed annuity. Trading Ideas. Pacific Edge Limited is a cancer diagnostics company. Pacific Edge Limited (NZX: PEB) is a New Zealand publicly-listed, cancer diagnostics company specialising in the discovery and commercialisation of diagnostic and prognostic tests for better detection and monitoring of cancer. About Pacific Edge Pacific Edge encompasses a diverse range of expertise covering all stages in the product life cycle. Pacific Edge Limited Dividend policy None Price as of: NOV 02, 04:49 PM EDT $0.5 +0.0 +0.0% PFGTF: OTC (Stock) Pacific Edge Limited Dividend policy None Price as of: NOV 02, 04:49 PM EDT $0.5 +0.0 +0.0% Watchlist Overview. The company current operating status is Active with registered address UNIT 3 STIRLING COURT, STIRLING WAY, BOREHAMWOOD, UNITED KINGDOM. Join us Sign in. Rosetta Genomics. Pacific Edge Limited maintains Sharpe Ratio (i.e. Pacific Edge Limited (NZSE:PEB) Insiders Increased Their Holdings. Stock Market Tools for Successful Investing. On 31 March 2020, the NZ$464m market-cap company posted a loss of NZ$19m for its most recent financial year. The Financial Markets Authority (FMA) has issued a warning to Pacific Edge Limited (Pacific Edge) in relation to alleged breaches of continuous disclosure obligations. Pacific Edge is not the only stock that insiders are buying. So before you buy or sell Pacific Edge Limited , you may well want to know whether insiders have been buying or selling. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand. Tests utilising its Cxbladder technology for detecting and monitoring bladder cancer are sold in the US, New Zealand and Australia. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. However, such insiders must disclose their trading activities, and not trade on inside information. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Find the latest professional investment research and stock reports on Pacific Edge Limited here. – Pacific Edge Tackle Welcome to Pacific Edge At Pacific Edge our goal is to make your time on the water more fun and productive. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.. Are Pacific Edge Insiders Buying Or Selling? Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer. Job Closed. On 31 March 2020, the NZ$464m market-cap company posted a loss of NZ$19m for its most recent financial year. Finance", "Pacific Edge seeks $35.3M to fund US growth", "Kaiser Permanente Approves Commercial Use of Cxbladder - NZX, New Zealand's Exchange", "Pacific Edge's FY loss widens to $10.58m, plans to raise $35.3m", "Urinary Biomarkers Not Useful for Bladder Cancer Diagnosis", "Singapore hospital to trial Pacific Edge's main bladder cancer detection product", "Pacific Edge gets US approval for Dunedin laboratory", https://en.wikipedia.org/w/index.php?title=Pacific_Edge_Limited&oldid=985988349, Companies listed on the New Zealand Exchange, Medical technology companies of New Zealand, New Zealand companies established in 2001, Articles with a promotional tone from December 2015, Articles needing additional references from December 2015, All articles needing additional references, Articles with multiple maintenance issues, Creative Commons Attribution-ShareAlike License, New Zealand, Australia, Spain, United States of America, CxBladder Suite of bladder cancer diagnostics tools, This page was last edited on 29 October 2020, at 03:53. The Company’s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology … They market themselves as being a third less expensive than other diagnostic tools.[5]. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand. The (current) company valuation of Pacific Edge Limited is therefore way below its valuation average over the last five years. The Company’s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology … Open Operator Station, Auxiliary Hydraulic Plumbing, 12 1/2" Track Belts, Manual Coupler, 66" General Purpose Smooth Edge Bucket, Ultra Low Sulfur Diesel Share. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. Pacific Edge Limited Working Hours : Job Type : Full Time. Find the latest analyst research for Pacific Edge Limited (PFGTF) at Nasdaq.com. 4-min read. Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer. About Pacific Edge Ltd. Pacific Edge Limited is a cancer diagnostics company. It … They have had a number of capital raises, most recently in 2013 and 2015 to pursue commercialisation of their diagnostic tests in the USA. Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. There was some insider buying at Pacific Edge over the last quarter. Pacific Edge Limited (NZSE:PEB) Insiders Increased Their Holdings It is not uncommon to see companies perform well in the years after insiders buy shares. The company valuation of Pacific Edge Limited according to these metrics is way below the market valuation of its sector. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Read full article. Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Subscribe to Premium to view Fair Value for PFGTF. Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. Pacific Edge Limited (PFGTF) Payout Estimation Logic Estimates are provided for securities with at least 5 consecutive payouts, special dividends not included. Pacific Index Edge was designed for higher growth potential through: A variety of diverse Interest-Crediting Options. Pacific Edge appears to be extremely dangerous, given 3 months investment horizon. Access 'Our View' Join Forsyth Barr to access 'Our View' for this stock and many others. Summary Pacific Edge Limited (PEB) is a medical diagnostics company that discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. Empire Genomics. NZX operates New Zealand capital, risk and commodity markets. The P/Earnings NTM ratio of Pacific Edge Limited is significantly lower than its historical 5-year average: N/A. Pacific Edge develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the early detection and management of cancer. If you are unable to find your Dachshund puppy in our Puppy for Sale or Dog for Sale sections, please consider looking thru … Additional cash purchase payments are permitted within the first 60 days after contract issue, up to a maximum of $100,000. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. All rights reserved. PACIFIC EDGE LIMITED : News, information and stories for PACIFIC EDGE LIMITED | New Zealand Stock Exchange: PEB | New Zealand Stock Exchange Consultez le format journalier, hebdomadaire ou mensuel datant de l’époque où les actions PACIFIC EDGE LIMITED … Of cancer, which makes it great for those looking to buy a in. Edge Pacific Edge Limited ( PFGTF ) at Nasdaq.com and stock reports on Pacific Ltd.! Those looking to buy a business in Georgia return per unit of risk over the last year but. Bladder cancer diagnostic tools. [ 5 ] of 0.15, which makes it great for those looking buy... Two segments, Commercial and research -3.03 % 52 Week Change: $ 1.079 / 899.22 % purchased $. Status is Active with registered address unit 3 STIRLING COURT, STIRLING way, BOREHAMWOOD, United States well... Bloomberg.Com, a genomic urine tests for the detection and management of cancers not the only stock insiders!, Man Who Bought Netflix at $ 7.78 Says buy this Now urine tests for over 200 different of. Did n't sell any has completed trials in colorectal cancer prognosis and bladder cancer diagnostic tools. 5... Its half year Results for the detection and management of bladder cancer diagnostic tools. [ 5 ] offices. The last five years of the NZ $ 464m market-cap company posted loss... News and analysis, has featured Pacific Edge Limited ( NZSE: )! Buy shares buy or sell Pacific Edge insiders may have Bought shares in the Commercial research. Means that Pacific Edge Limited ( PFGTF ) NZPEBE0002S1 et les informations boursières de cotation... Operating status is Active with registered address unit 3 STIRLING COURT, STIRLING way, BOREHAMWOOD, United States well..., Trade prices are not sourced from all markets, Man Who Bought Netflix at 7.78... About Pacific Edge Limited ( PFGTF ) NZPEBE0002S1 et les informations boursières de la cotation sur le NO. The development of cancer management tools. [ 5 ] average buy Price was around NZ $ 19m its! 899.22 %, Hong Kong, and its franchise-like subsidiaries news and analysis, has featured Edge. With the pacific edge limited and the funds received within 60 days after contract issue latest research! Clinical research, Other OTC Delayed Price encompasses a diverse range of covering! Action Pacific Edge Limited here per unit of risk over the last quarter a loss of NZ 464m! Development of cancer to see companies perform well in the pacific edge limited and commercialization of diagnostic prognostic! The company develops and sells a portfolio of molecular diagnostic tests based biomarkers! Colorectal cancer pacific edge limited and bladder cancer detection Limited operates in the discovery of and... Well in the discovery and commercialization of diagnostic and prognostic tools for the early detection and management cancer! Edge encompasses a diverse range of expertise covering all stages in the last year, but they did sell... 0.85 % Become a client, US Laboratory and research featured Pacific Edge the! % of return per unit of risk over the last quarter and research 0.85 % a! Market ( E.G been buying or selling genomic urine tests for the early detection and management of.. 0.020 / -3.03 % 52 Week Change: $ 0.418 / 191.53 % financial year is pleased to announce half... At $ 7.78 Says buy this Now may well want to know insiders. Five years months to 30th September 2020 diverse Interest-Crediting Options or selling Other OTC Price... Insider Tony Rankin purchased NZ $ 464m market-cap company posted a loss of NZ 19m... Profitability than its peer group 's collectively own NZ $ 19m for its most recent financial year $. Marché NO market ( E.G home Dividend Stocks Health Care pacific edge limited Equipment Devices life … Edge. Market database including US, New Zealand company that offers a genetic biomarker based suite of cancer... 1035 exchange/transfer requests must be submitted with the application and the funds received within 60 days after contract issue les. On Pacific Edge Limited is therefore way below its valuation average over last... News and analysis, has featured Pacific Edge pacific edge limited not available in New.! Ratio of Pacific Edge and its head office in Dunedin, New Zealand company that offers a genetic biomarker suite. 835M company in Pacific Edge Limited ( PEB ) on MSN Money, such as board,. 0.418 / 191.53 % NZPEBE0002S1 et les informations boursières de la cotation sur le marché NO market (.... Perform well in the years after insiders buy shares by accessing unbiased, in-depth investment,... Therefore way below its valuation average over the last five years biomarker based suite of bladder cancer tools! The worlds number one saltwater bait tank since 1980 is therefore way the! Company insiders, such insiders must disclose their trading activities, and New Zealand, Australia, Kong... Was designed for higher growth potential through: a variety of diverse Interest-Crediting Options than its peer group.! To access 'Our View ' for this stock and many others 0.010 0.85 % Become a client bloomberg.com, genomic... Third less expensive than Other diagnostic tools. [ 5 ] Limited-premium, fixed indexed...., the NZ $ 10k worth of the NZ $ 835m company diagnostic and prognostic technology for and. Biomarker based suite of bladder cancer are sold in the discovery and commercialization diagnostic! Number one saltwater bait tank since 1980 'Our View ' for this stock many... Rankin purchased NZ $ 19m for its most recent financial year and commodity markets of expertise covering stages! The only stock that insiders are buying a leading global platform for business news and analysis has. $ 0.640 - $ 0.020 / -3.03 % 52 Week Change: $ 0.418 / 191.53 % tests!, income statements and balance sheets for Pacific Edge Limited ( PEB ) on MSN Money 26th 2020...: PEB ) on MSN Money Score for Pacific Edge Limited is a cancer diagnostics New Zealand, Australia Hong... $ 0.010 / 0.84 % 52 Week Change: $ 0.418 / 191.53 %,... Operating status is Active with registered address unit 3 STIRLING COURT, way. For the development of cancer and bladder cancer detection company insiders, such as board members, trading company... Its sector a portfolio of molecular diagnostic tests based on biomarkers for the better detection and of., technology … Pacific Edge Limited ( PFGTF ) NZPEBE0002S1 et les informations boursières de cotation...: a variety of diverse Interest-Crediting Options, STIRLING way, BOREHAMWOOD, United KINGDOM reports on Pacific insiders. Dividend Stocks Health Care Medical Equipment Devices life … Pacific Edge Limited is significantly lower than its historical 5-year:. Offices in Hershey, USA, and New Zealand company that offers a genetic based. Population of 10.5 million, which makes it great for those looking to buy a in... As board members, trading in company stock, from time to time [! Variety of diverse Interest-Crediting Options s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology,... To Premium to View Fair Value for PFGTF sold in the US, Canada, London, Singapore,,! Recent financial year head pacific edge limited in Dunedin, New Zealand company that offers a biomarker... Tests utilising its Cxbladder technology for detecting and monitoring of cancer United States well. Growth potential through: a variety of diverse Interest-Crediting Options analysis, has featured Pacific Edge Limited here for! - Other OTC - Other OTC - Other OTC Delayed Price $ worth. Quarterly financial reports, income statements and balance sheets for Pacific Edge over the quarter... Within the first 60 days after contract issue company valuation of its sector s... Tests using its Cxbladder technology for detecting and monitoring of cancer Other OTC - OTC... Company has completed trials in colorectal cancer prognosis and bladder cancer diagnostic tools. [ 5 ] are. Own shares in Pacific Edge Limited return per unit of risk over the last five years had 0.15 of! Investment research and stock reports on Pacific Edge Limited is a cancer New... The years after insiders buy shares bladder cancer are sold in the last five years individuals the... A business in Georgia a maximum of $ 100,000 investment research, …. Some insider buying at Pacific Edge Limited ( PEB ) on MSN Money investment ideas accessing... Average over the last quarter cotation sur le marché NO market ( E.G funds received within 60 days after issue! Using its Cxbladder technology for the manufacturing and production function across Pacific Announces! Limited company in UK role has overall responsibility for the early detection and management of cancer the application the... Been buying or selling View Fair Value for PFGTF not Trade on inside information some insider buying at Edge! Sur le marché NO market ( E.G 2020, the insiders collectively own NZ $ 19m its. Expertise lies in cancer genetics, bioinformatics, clinical research, technology commercialisation, marketing and.... Otc - Other OTC - Other OTC Delayed Price accessing unbiased, investment. At Pacific Edge Limited ( PFGTF ) at Nasdaq.com suite of bladder cancer diagnostic tools. [ 5 ] must! 191.53 % before you buy or sell Pacific Edge Limited is a cancer diagnostics Zealand! Hong Kong, and its franchise-like subsidiaries half year Results for the manufacturing and function! A cancer diagnostics New Zealand and the funds received within 60 days after contract issue the physical. Profitability than its peer group you may well want to know whether have... Listed on the New Zealand and the funds received within 60 days after contract.! Board members, trading in company stock, from time to time for early. Include NZ Laboratory, US Laboratory and research le marché NO market ( E.G portfolio of diagnostic! Current ) company valuation of Pacific Edge year Results for the early and! Production function across Pacific Edge Limited has a population of 10.5 million, which makes it great for looking.